The cannabis producer’s stock shot up by 215 per cent on its first day of trading followed by a further 91 per cent increase yesterday.
Companies across the cannabis industry announce financial results for the first quarter of 2022, Cannabis Wealth rounds up the results
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for
The platform aims to be a premium destination for industry members to connect.
Akanda has now completed its acquisition of Holigen Limited from The Flowr Corporation.
A new cannabis-themed ETF has launched this 4/20 giving investors the opportunity to capitalise on the growing North American market.
The new Prohibition Partners report projects that sales of adult-use cannabis in Europe could reach €1.5bn by 2026.
Promising results reported from studies testing the efficacy of its lead compound.
Inflation is at a record high, but cannabis prices are continuing to fall.
The CBX Stock Exchange will offer “seed to shelf” transparency.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
